omniture

China Medical Technologies to Announce Unaudited Financial Results for the Third Fiscal Quarter Ended December 31, 2009 on March 3, 2010

2010-02-08 20:18 1035

BEIJING, Feb. 8 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009") before the U.S. market opens on March 3, 2010. The Company's 2009 fiscal year ends on March 31, 2010.

The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on March 3, 2010 (9:00 p.m. Beijing/Hong Kong time on March 3, 2010).

Conference Call

The dial-in details for the live conference call are as follows:

-- U.S. Toll Free Number 1-866-713-8562

-- International Dial-in Number 1-617-597-5310

Passcode: CMEDCALL

A live webcast of the conference call will be available on http://ir.chinameditech.com .

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on March 4, 2010. The dial-in details for the replay are as follows:

-- U.S. Toll Free Number 1-888-286-8010

-- International Dial-in Number 1-617-801-6888

Passcode: 33530003

About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech.com .

For more information, please contact:

Winnie Yam

Phone: +852-2511-9808

Email: IR@chinameditech.com

Source: China Medical Technologies, Inc.
Related Stocks:
NASDAQ:CMED
collection